Search
Washington Paid Clinical Trials
A listing of 1729 clinical trials in Washington actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1621 - 1632 of 1729
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Location
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
Washington is currently home to 1729 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Seattle, Spokane, Tacoma and Vancouver. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Buy Retatrutide Online Through Celia
Recruiting
Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.
Conditions:
Healthy
Featured Offer
Lose 20% of Body Weight With GLP-1's
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).
Get $50 off your first order using promo code: policy-lab-50
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).
Get $50 off your first order using promo code: policy-lab-50
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Trial
Birth Control Clinical Research Study
Recruiting
Living with obesity and looking for a birth control option that is right for you? Clinical trials are now enrolling women with a body mass index (BMI) of 30 or more in the area to help study a potential new progestin-only contraceptive patch. Participating in research studies can help advance birth control options. Don’t let financial stress hold you back. All study-related assessments, care, and study patch are available at no cost. You may also be reimbursed for study-related travel.
Conditions:
Obesity
Overweight
Overweight and Obesity
Featured Trial
Depression Clinical Trial
Recruiting
Join us in researching a potential investigational treatment for Depression. Reimbursement for study-related expenses may be available to you.
Qualifying participants:
•Are between 18-65
•Have been experiencing a major depressive episode for at least a month
Qualifying participants:
•Are between 18-65
•Have been experiencing a major depressive episode for at least a month
Conditions:
Depression
Major Depressive Disorder
Depressive Disorder
Depressive Symptoms
Depressive Disorder
Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism
Recruiting
The goal of this proposed trial will modify an existing toothbrushing app for teens with autism and compare toothbrushing outcomes with a control app. We have 2 specific aims:
* During the 2-year UG3 phase, we will use the Discover, Design+Build, and Test Framework to modify our existing app and pilot the intervention.
* During the 4-year UH3 phase, we will recruit 270 pre-adolescents and teens with autism ages 10 to 17 years, randomize participants to one of two arms, and compare outcomes.
Pa... Read More
Gender:
ALL
Ages:
Between 10 years and 17 years
Trial Updated:
05/06/2024
Locations: University of Washington, Seattle, Washington
Conditions: Autism
Caring for Vets and Service Members: Caring Contacts for Stressed and Distressed Veterans and Service Members
Recruiting
The goal of this clinical trial is to study stressed or distressed veterans and service members. Researchers will compare Caring Contacts plus best available resources to best available resources alone to see if reduces distress and prevents thoughts of suicide.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/06/2024
Locations: University of Washington, Seattle, Washington
Conditions: Stress, Distress, Emotional
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Recruiting
This is a prospective clinical research study to test the effectiveness of the Levonorgestrel (LNG) 52 mg Intrauterine Device (IUD) for emergency contraception (EC) and same-day start use that will enroll people receiving care at Planned Parenthood affiliates across the U.S. Our prior work demonstrated efficacy (shows that it works in an ideal setting) for the LNG 52 mg IUD for these uses and this study will test effectiveness (how well it works in the real world) in a larger, heterogenous popul... Read More
Gender:
FEMALE
Ages:
Between 16 years and 35 years
Trial Updated:
05/06/2024
Locations: Planned Parenthood Great Northwest Hawaii, Alaska, Indiana, Kentucky, Seattle, Washington
Conditions: Contraception
Smart Eyewear to Automatically Detect Drug Delivery Events
Recruiting
This project is designed as a prospective observational study of medication preparation and delivery using a novel wearable data input device to automate detection of drug delivery events in the anesthesia workspace at University of Washington Medical Center.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/06/2024
Locations: University of Washington, Seattle, Washington
Conditions: Smart Eyewear
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
Recruiting
This study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on 2 commercially available SOC treatments for Diabetic Foot Wounds.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: United Wound Healing P.S, Auburn, Washington
Conditions: Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
Recruiting
All4Cure is partnering with community oncology practices participating in the Quality Cancer Care Alliance (QCCA) and Exigent Research to develop a clinical pathway that standardizes the evaluation, treatment and ongoing management of patients with newly diagnosed multiple myeloma who wish to achieve and maintain MRD negativity.
This is a longitudinal retrospective study that will collect data from three separate cohorts of patients with newly diagnosed multiple myeloma (NDMM). The cohorts clas... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/02/2024
Locations: All4Cure, Seattle, Washington
Conditions: Multiple Myeloma, Multiple Myeloma Without Mention of Remission
A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing
Recruiting
This is a prospective, multi-center study within the U.S. Study participants will take part in two study visits a minimum of 14 days apart. During each visit, participants will self-collect capillary blood samples. Additionally, a healthcare provide will obtain capillary and venous serum samples. All capillary samples will be collected from the upper arm using the Tasso+ device paired with a commercially-available serum separator gel microtainer. The samples will be shipped to a clinical laborat... Read More
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
04/30/2024
Locations: Tasso Research Clinic, Seattle, Washington
Conditions: Serum Analytes
NIH Release/Relock Socket
Recruiting
The goal of the research is to create and evaluate a new technology for management of daily residual limb fluid volume fluctuation.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/25/2024
Locations: University of Washington Bioengineering, Seattle, Washington
Conditions: Lower Limb Amputation Below Knee (Injury)
Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population
Recruiting
The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.
Gender:
ALL
Ages:
All
Trial Updated:
04/18/2024
Locations: Viome Life Sciences, Bothell, Washington
Conditions: General Health, Wellness
Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
Recruiting
The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.
Gender:
FEMALE
Ages:
All
Trial Updated:
04/18/2024
Locations: Seattle Childrens Hospital, Seattle, Washington
Conditions: Twin to Twin Transfusion as Antepartum Condition, Monochorionic Diamniotic Placenta
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Recruiting
The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/17/2024
Locations: University of Washington, Department of Ophthalmology, Seattle, Washington
Conditions: Neurotrophic Keratopathy
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Recruiting
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Gender:
ALL
Ages:
All
Trial Updated:
04/17/2024
Locations: Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance, Seattle, Washington
Conditions: Infusion Reactions